310 related articles for article (PubMed ID: 22404134)
1. p21-Activated kinase inhibitors: a patent review.
Crawford JJ; Hoeflich KP; Rudolph J
Expert Opin Ther Pat; 2012 Mar; 22(3):293-310. PubMed ID: 22404134
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of p21-activated kinases (PAKs).
Rudolph J; Crawford JJ; Hoeflich KP; Wang W
J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
Szczepanowska J
Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinase inhibitors.
Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
[TBL] [Abstract][Full Text] [Related]
5. Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain.
Kim DJ; Choi CK; Lee CS; Park MH; Tian X; Kim ND; Lee KI; Choi JK; Ahn JH; Shin EY; Shin I; Kim EG
Exp Mol Med; 2016 Apr; 48(4):e229. PubMed ID: 27126178
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the SH3 domain of beta-PIX and its interaction with alpha-p21 activated kinase (PAK).
Mott HR; Nietlispach D; Evetts KA; Owen D
Biochemistry; 2005 Aug; 44(33):10977-83. PubMed ID: 16101281
[TBL] [Abstract][Full Text] [Related]
7. The genetics of Pak.
Hofmann C; Shepelev M; Chernoff J
J Cell Sci; 2004 Sep; 117(Pt 19):4343-54. PubMed ID: 15331659
[TBL] [Abstract][Full Text] [Related]
8. Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors.
Crawford JJ; Lee W; Aliagas I; Mathieu S; Hoeflich KP; Zhou W; Wang W; Rouge L; Murray L; La H; Liu N; Fan PW; Cheong J; Heise CE; Ramaswamy S; Mintzer R; Liu Y; Chao Q; Rudolph J
J Med Chem; 2015 Jun; 58(12):5121-36. PubMed ID: 26030457
[TBL] [Abstract][Full Text] [Related]
9. Phylogenetic and structural analysis of the Drosophila melanogaster p21-activated kinase DmPAK3.
Mentzel B; Raabe T
Gene; 2005 Apr; 349():25-33. PubMed ID: 15777717
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the Cdc42/Rac-binding domain of p21-activated kinase.
Thompson G; Owen D; Chalk PA; Lowe PN
Biochemistry; 1998 May; 37(21):7885-91. PubMed ID: 9601050
[TBL] [Abstract][Full Text] [Related]
11. Identification of allosteric inhibitors of p21-activated kinase.
Viaud J; Peterson JR
Methods Mol Biol; 2012; 928():67-79. PubMed ID: 22956134
[TBL] [Abstract][Full Text] [Related]
12. P21 activated kinase signaling in cancer.
Rane CK; Minden A
Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
[TBL] [Abstract][Full Text] [Related]
13. Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cells.
Funk SD; Yurdagul A; Green JM; Jhaveri KA; Schwartz MA; Orr AW
Circ Res; 2010 Apr; 106(8):1394-403. PubMed ID: 20224042
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M; Muth F; Koch P; Laufer SA
Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of activation of Pak1 kinase by membrane localization.
Lu W; Mayer BJ
Oncogene; 1999 Jan; 18(3):797-806. PubMed ID: 9989831
[TBL] [Abstract][Full Text] [Related]
17. A RAC/CDC-42-independent GIT/PIX/PAK signaling pathway mediates cell migration in C. elegans.
Lucanic M; Cheng HJ
PLoS Genet; 2008 Nov; 4(11):e1000269. PubMed ID: 19023419
[TBL] [Abstract][Full Text] [Related]
18. P21 activated kinases: structure, regulation, and functions.
Rane CK; Minden A
Small GTPases; 2014; 5():. PubMed ID: 24658305
[TBL] [Abstract][Full Text] [Related]
19. Conformational switch and role of phosphorylation in PAK activation.
Buchwald G; Hostinova E; Rudolph MG; Kraemer A; Sickmann A; Meyer HE; Scheffzek K; Wittinghofer A
Mol Cell Biol; 2001 Aug; 21(15):5179-89. PubMed ID: 11438672
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors.
Gul M; Fakhar M; Najumuddin ; Rashid S
PLoS One; 2019; 14(11):e0225132. PubMed ID: 31738805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
